Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 50 of 235 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/02/15
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 07/18/22
End: 12/22/23
Due: 12/22/24
Phase: N/A
Priority: Normal
Start: 01/07/20
End: 03/06/24
Due: 03/06/25
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 04/01/25
End: 09/04/26
Due: 09/04/27
Phase: N/A
Priority: Normal
Start: 03/27/25
End: 04/01/25
Due: 04/01/26
Phase: N/A
Priority: Normal
Start: 04/24/19
End: 04/30/29
Due: 04/30/30
Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 04/02/24
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 12/16/21
End: 12/22/27
Due: 12/22/28
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 07/31/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/13
End: 08/31/43
Due: 08/31/44
Phase: N/A
Priority: Normal
Start: 06/25/21
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 05/08/14
End: 05/27/20
Due: 05/27/21
Phase: N/A
Priority: Normal
Start: 10/20/23
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 07/15/22
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 03/25/24
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 06/12/22
End: 02/28/26
Due: 02/28/27
Phase: N/A
Priority: Normal
Start: 05/10/21
End: 04/30/26
Due: 04/30/27
Comprehensive Assessment of Nutrition and Dietary Intervention in Hypermobile Ehlers Danlos Syndrome
Phase: N/A
Priority: Normal
Start: 04/07/22
End: 07/03/23
Due: 07/03/24
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 04/30/18
Due: 04/30/19
Phase: N/A
Priority: Normal
Start: 12/21/17
End: 08/18/23
Due: 08/18/24
Phase: N/A
Priority: Normal
Start: 02/15/17
End: 01/30/20
Due: 01/30/21